Cargando…

Comparison of Efficacy of Long‐term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease

BACKGROUND: The efficacy and benefits of telmisartan in cats with chronic kidney disease (CKD) have not previously been reported. HYPOTHESIS: Long‐term treatment of cats with CKD using telmisartan decreases urine protein‐to‐creatinine ratio (UP/C) similar to benazepril. ANIMALS: Two‐hundred and twen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sent, U., Gössl, R., Elliott, J., Syme, H. M., Zimmering, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895689/ https://www.ncbi.nlm.nih.gov/pubmed/26474314 http://dx.doi.org/10.1111/jvim.13639

Ejemplares similares

Efficacy of long‐term oral telmisartan treatment in cats with hypertension: Results of a prospective European clinical trial
por: Glaus, Tony M., et al.
Publicado: (2018)

Safety and efficacy of orally administered telmisartan for the treatment of systemic hypertension in cats: Results of a double‐blind, placebo‐controlled, randomized clinical trial
por: Coleman, Amanda E., et al.
Publicado: (2019)

Clinical efficacy of a benazepril and spironolactone combination in dogs with congestive heart failure due to myxomatous mitral valve disease: The BEnazepril Spironolactone STudy (BESST)
por: Coffman, Melissa, et al.
Publicado: (2021)

Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo‐controlled clinical trial
por: King, Jonathan N., et al.
Publicado: (2019)

Evaluation of oral telmisartan administration as a suppression test for diagnosis of primary hyperaldosteronism in cats
por: Fabrès, Virginie, et al.
Publicado: (2023)

Erratum for Comparison of Efficacy of Long‐term Oral Treatment with Telmisartan and Benazepril in Cats with Chronic Kidney Disease (pages 1479–1487)
Publicado: (2016)

Risk Factors for Development of Chronic Kidney Disease in Cats
por: Finch, N.C., et al.
Publicado: (2016)

Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo‐Controlled Clinical Trial
por: King, J.N., et al.
Publicado: (2017)

Psychometric Validation of a General Health Quality of Life Tool for Cats Used to Compare Healthy Cats and Cats with Chronic Kidney Disease
por: Bijsmans, E.S., et al.
Publicado: (2016)

Serum Cystatin C Concentrations in Cats with Hyperthyroidism and Chronic Kidney Disease
por: Williams, T.L., et al.
Publicado: (2016)

Long‐term Outcome of Irish Wolfhound Dogs with Preclinical Cardiomyopathy, Atrial Fibrillation, or Both Treated with Pimobendan, Benazepril Hydrochloride, or Methyldigoxin Monotherapy
por: Vollmar, A.C., et al.
Publicado: (2016)

Relationship between Plasma Fibroblast Growth Factor‐23 Concentration and Survival Time in Cats with Chronic Kidney Disease
por: Geddes, R.F., et al.
Publicado: (2015)

Prospective evaluation of a telmisartan suppression test as a diagnostic tool for primary hyperaldosteronism in cats
por: Kurtz, Maxime, et al.
Publicado: (2023)

Development of an estimated glomerular filtration rate formula in cats
por: Finch, Natalie C., et al.
Publicado: (2018)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021)

The association of bacteriuria with survival and disease progression in cats with azotemic chronic kidney disease
por: Hindar, Camilla, et al.
Publicado: (2020)

Changes in thyroid and renal function after bilateral thyroidectomy in cats
por: Covey, Heather L., et al.
Publicado: (2019)

The Effect of Moderate Dietary Protein and Phosphate Restriction on Calcium‐Phosphate Homeostasis in Healthy Older Cats
por: Geddes, R.F., et al.
Publicado: (2016)

Breed, Coat Color, and Hair Length as Risk Factors for Hyperthyroidism in Cats
por: Crossley, V.J., et al.
Publicado: (2017)

Treatment of proteinuria in dogs with telmisartan: A retrospective study
por: Lecavalier, Julie, et al.
Publicado: (2021)

Efficacy of telmisartan for the treatment of persistent renal proteinuria in dogs: A double‐masked, randomized clinical trial
por: Lourenço, Bianca N., et al.
Publicado: (2020)

Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease
por: Paschall, Rene E., et al.
Publicado: (2023)

Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia
por: van den Broek, D.H.N., et al.
Publicado: (2017)

Factors Influencing the Relationship Between the Dose of Amlodipine Required for Blood Pressure Control and Change in Blood Pressure in Hypertensive Cats
por: Bijsmans, E.S., et al.
Publicado: (2016)

Risk factors for upper urinary tract uroliths and ureteral obstruction in cats under referral veterinary care in the United Kingdom
por: Geddes, Rebecca F., et al.
Publicado: (2023)

Plasma N‐Terminal Probrain Natriuretic Peptide, Vascular Endothelial Growth Factor, and Cardiac Troponin I as Novel Biomarkers of Hypertensive Disease and Target Organ Damage in Cats
por: Bijsmans, E.S., et al.
Publicado: (2017)

Treatment failure in hyperthyroid cats after radioiodine (I‐131) injection
por: Mullowney, Deirdre, et al.
Publicado: (2021)

Ionized hypercalcemia in cats with azotemic chronic kidney disease (2012‐2018)
por: van den Broek, Dirk Hendrik Nicolaas, et al.
Publicado: (2022)

Thirty‐two cats with effusive or non‐effusive feline infectious peritonitis treated with a combination of remdesivir and GS‐441524
por: Green, Jodie, et al.
Publicado: (2023)

Risk factors and implications associated with renal mineralization in chronic kidney disease in cats
por: Tang, Pak‐Kan, et al.
Publicado: (2022)

An artificial neural network‐based model to predict chronic kidney disease in aged cats
por: Biourge, Vincent, et al.
Publicado: (2020)

Calcitonin Response to Naturally Occurring Ionized Hypercalcemia in Cats with Chronic Kidney Disease
por: van den Broek, D.H.N., et al.
Publicado: (2018)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Fowler, Brittany L., et al.
Publicado: (2021)

Ionized hypercalcemia in 238 cats from a referral hospital population (2009‐2019)
por: Broughton, Sophie E., et al.
Publicado: (2023)

Prognostic importance of plasma total magnesium in a cohort of cats with azotemic chronic kidney disease
por: van den Broek, D. Hendrik N., et al.
Publicado: (2018)

Iron Status of Cats with Chronic Kidney Disease
por: Gest, J., et al.
Publicado: (2015)

Hyperthyroid cats and their kidneys: a literature review
por: Yu, L, et al.
Publicado: (2022)

Echocardiographic and biomarker evidence of plasma volume expansion after short‐term steroids administered orally in cats
por: Block, Chloё L., et al.
Publicado: (2019)

Long‐term incidence and risk of noncardiovascular and all‐cause mortality in apparently healthy cats and cats with preclinical hypertrophic cardiomyopathy
por: Fox, Philip R., et al.
Publicado: (2019)

Evaluation of and the prognostic factors for cats with big kidney‐little kidney syndrome
por: Wu, Yen‐Tse, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1o039uhk9pjosiamj768eaq7k2